The TCA cycle is not required for selection or survival of multidrug-resistant Salmonella

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 3, 2012, Pages 589-599

  Ricci, Vito ^a   Loman, Nick ^a   Pallen, Mark ^a   Ivens, Alasdair ^b,c   Fookes, Maria ^b   Langridge, Gemma C ^b   Wain, John ^b,d   Piddock, Laura J V ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c Fios Genomics Ltd   (United Kingdom)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Efflux pumps; Genome sequences; RamR; TctA

Indexed keywords

CIPROFLOXACIN; GLYCOGEN; NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; REACTIVE OXYGEN METABOLITE; TRANSCRIPTOME;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL MEMBRANE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; CELL MOTILITY; CITRIC ACID CYCLE; ENERGY YIELD; GENE EXPRESSION; GENE INACTIVATION; GENE SEQUENCE; MULTIDRUG RESISTANCE; MUTATION RATE; NONHUMAN; PHENOTYPE; SALMONELLA TYPHIMURIUM; SINGLE NUCLEOTIDE POLYMORPHISM; SITE DIRECTED MUTAGENESIS;

ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; CITRIC ACID CYCLE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MICROBIAL VIABILITY; MUTAGENESIS, SITE-DIRECTED; MUTATION; REACTIVE OXYGEN SPECIES; SALMONELLA TYPHIMURIUM; SELECTION, GENETIC; SYSTEMS BIOLOGY; TRANSCRIPTOME;

EID: 84856960075     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr515     Document Type: Article

References (52)

1. Angulo FJ, Nargund VN, Chiller TC. Evidence of an association between use of anti-microbial agents in food animals and anti-microbial resistance among bacteria isolated from humans and the human health consequences of such resistance. J Vet Med B Infect Dis Vet Public Health 2004; 51: 374-9.
2. Mølbak K, Baggesen DL, Aarestrup FM et al. An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype typhimurium DT104. N Engl J Med 1999; 341: 1420-5.
3. Su LH, Wu TL, Chia JH et al. Increasing ceftriaxone resistance in Salmonella isolates from a university hospital in Taiwan. J Antimicrob Chemother 2005; 55: 846-52.
4. Varma JK, Greene KD, Ovitt J et al. Hospitalization and antimicrobial resistance in Salmonella outbreaks, 1984-2002. Emerg Infect Dis 2005; 11: 943-6.
5. Everett MJ, Jin YF, Ricci V et al. Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals. Antimicrob Agents Chemother 1996; 40: 2380-6.
6. Hächler H, Cohen SP, Levy SB. marA, a regulated locus which controls expression of chromosomal multiple antibiotic resistance in Escherichia coli. J Bacteriol 1991; 173: 5532-8.
7. Abouzeed YM, Baucheron S, Cloeckaert A. ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother 2008; 52: 2428-34.
8. Bailey AM, Paulsen IT, Piddock LJ. RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine. Antimicrob Agents Chemother 2008; 52: 3604-11.
9. Kehrenberg C, Cloeckaert A, Klein G et al. Decreased fluoroquinolone susceptibility in mutants of Salmonella serovars other than Typhimurium: detection of novel mutations involved in modulated expression of ramA and soxS. J Antimicrob Chemother 2009; 64: 1175-80.
10. O'Regan E, Quinn T, Pagès JM et al. Multiple regulatory pathways associated with high-level ciprofloxacin and multidrug resistance in Salmonella enterica serovar Enteritidis: involvement of RamA and other global regulators. Antimicrob Agents Chemother 2009; 53: 1080-7.
11. Ricci V, Piddock LJ. Ciprofloxacin selects for multidrug resistance in Salmonella enterica serovar Typhimurium mediated by at least two different pathways. J Antimicrob Chemother 2009; 63: 909-16.
12. Zheng J, Cui S, Meng J. Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium. J Antimicrob Chemother 2009; 63: 95-102.
13. Piddock LJ. Multidrug-resistance efflux pumps - not just for resistance. Nat Rev Microbiol 2006; 4: 629-36.
14. Cairns J, Foster PL. Adaptive reversion of a frameshift mutation in Escherichia coli. Genetics 1991; 128: 695-701.
15. Riesenfeld C, Everett M, Piddock LJ et al. Adaptive mutations produce resistance to ciprofloxacin. Antimicrob Agents Chemother 1997; 41: 2059-60.
16. Gonzalez C, Hadany L, Ponder RG et al. Mutability and importance of a hypermutable cell subpopulation that produces stress-induced mutants in Escherichia coli. PLoS Genet 2008; 4: e1000208.
17. Torkelson J, Harris RS, Lombardo MJ et al. Genome-wide hypermutation in a subpopulation of stationary-phase cells underlies recombination-dependent adaptive mutation. EMBO J 1997; 16: 3303-11.
18. Koskiniemi S, Hughes D, Andersson DI. Effect of translesion DNA polymerases, endonucleases and RpoS on mutation rates in Salmonella typhimurium. Genetics 2010; 185: 783-95.
19. Dwyer DJ, Kohanski MA, Hayete B et al. Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli. Mol Syst Biol 2007; 3: 91.
20. Shaw KJ, Miller N, Liu X et al. Comparison of the changes in global gene expression of Escherichia coli induced by four bactericidal agents. J Mol Microbiol Biotechnol 2003; 5: 105-22.
21. Kohanski MA, Dwyer DJ, Hayete B et al. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 2007; 130: 797-810.
22. Kohanski MA, DePristo MA, Collins JJ. Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis. Mol Cell 2010; 37: 311-20.
23. Kaufmann BB, Hung DT. The fast track to multidrug resistance. Mol Cell 2010; 37: 297-8.
24. Wray C, Sojka WJ. Experimental Salmonella typhimurium infection in calves. Res Vet Sci 1978; 25: 139-43.
25. Ricci V, Tzakas P, Buckley A et al. Ciprofloxacin-resistant Salmonella enterica serovar Typhimurium strains are difficult to select in the absence of AcrB and TolC. Antimicrob Agents Chemother 2006; 50: 38-42.
26. Bailey AM, Ivens A, Kingsley R et al. RamA, a member of the AraC/XylS family, influences both virulence and efflux in Salmonella enterica serovar Typhimurium. J Bacteriol 2010; 192: 1607-16.
27. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 2000; 97: 6640-5.
28. Andrews JM. BSAC standardized disc susceptibility testing method (version 7). J Antimicrob Chemother 2008; 62: 256-78.
29. Webber MA, Bailey AM, Blair JM et al. The global consequence of disruption of the AcrAB-TolC efflux pump in Salmonella enterica includes reduced expression of SPI-1 and other attributes required to infect the host. J Bacteriol 2009; 191: 4276-85.
30. Zhou L, Lei XH, Bochner BR et al. Phenotype microarray analysis of Escherichia coli K-12 mutants with deletions of all two-component systems. J Bacteriol 2003; 185: 4956-72.
31. Piddock LJ, Traynor EA, Wise R. A comparison of the mechanisms of decreased susceptibility of aztreonam-resistant and ceftazidime-resistant Enterobacteriaceae. J Antimicrob Chemother 1990; 26: 749-62.
32. Morán-Zorzano MT, Alonso-Casajús N, Muñoz FJ et al. Occurrence of more than one important source of ADPglucose linked to glycogen biosynthesis in Escherichia coli and Salmonella. FEBS Lett 2007; 581: 4423-9.
33. Piddock LJ, White DG, Gensberg K et al. Evidence for an efflux pump mediating multiple antibiotic resistance in Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother 2000; 44: 3118-21.
34. Widenhorn KA, BoosW, Somers JM et al. Cloning and properties of the Salmonella typhimurium tricarboxylate transport operon in Escherichia coli. J Bacteriol 1988; 170: 883-8.
35. Khoramian-Falsafi T, Harayama S, Kutsukake K et al. Effect of motility and chemotaxis on the invasion of Salmonella typhimurium into HeLa cells. Microb Pathog 1990; 9: 47-53.
36. Altier C. Genetic and environmental control of Salmonella invasion. J Microbiol 2005; 43: 85-92.
37. Eichelberg K, Galán JE. Differential regulation of Salmonella typhimurium type III secreted proteins by pathogenicity island 1 (SPI-1)-encoded transcriptional activators InvF and hilA. Infect Immun 1999; 67: 4099-105.
38. Altier C, Suyemoto M, Ruiz AI et al. Characterization of two novel regulatory genes affecting Salmonella invasion gene expression. Mol Microbiol 2000; 35: 635-46.
39. Karp PD, Paley S, Romero P. The Pathway Tools software. Bioinformatics 2002; 18 Suppl 1: S225-32.
40. Gruer MJ, Bradbury AJ, Guest JR. Construction and properties of aconitase mutants of Escherichia coli. Microbiology 1997; 143: 1837-46.
41. Helling RB, Kukora JS. Nalidixic acid-resistant mutants of Escherichia coli deficient in isocitrate dehydrogenase. J Bacteriol 1971; 105: 1224-6.
42. Marcusson LL, Frimodt-Moller N, Hughes D. Interplay in the selection of fluoroquinolone resistance and bacterial fitness. PLoS Pathog 2009; 5: e1000541.
43. Björkman J, Nagaev I, Berg OG et al. Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science 2000; 287: 1479-82.
44. Andersson DI, Hughes D. Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol 2010; 8: 260-71.
45. Björkman J, Hughes D, Andersson DI. Virulence of antibiotic-resistant Salmonella typhimurium. Proc Natl Acad Sci USA 1998; 95: 3949-53.
46. Björkman J, Samuelsson P, Andersson DI et al. Novel ribosomal mutations affecting translational accuracy, antibiotic resistance and virulence of Salmonella typhimurium. Mol Microbiol 1999; 31: 53-8.
47. Nagaev I, Björkman J, Andersson DI et al. Biological cost and compensatory evolution in fusidic acid-resistant Staphylococcus aureus. Mol Microbiol 2001; 40: 433-9.
48. Giraud E, Cloeckaert A, Baucheron S et al. Fitness cost of fluoroquinolone resistance in Salmonella enterica serovar Typhimurium. J Med Microbiol 2003; 52: 697-703.
49. Wang YP, Li L, Shen JZ et al. Quinolone-resistance in Salmonella is associated with decreased mRNA expression of virulence genes invA and avrA, growth and intracellular invasion and survival. Vet Microbiol 2009; 133: 328-34.
50. Fàbrega A, du Merle L, Le Bouguénec C et al. Repression of invasion genes and decreased invasion in a high-level fluoroquinolone-resistant Salmonella typhimurium mutant. PLoS One 2009; 4: e8029.
51. O'Regan E, Quinn T, Frye JG et al. Fitness costs and stability of a high-level ciprofloxacin resistance phenotype in Salmonella enterica serotype Enteritidis: reduced infectivity associated with decreased expression of Salmonella pathogenicity island 1 genes. Antimicrob Agents Chemother 2010; 54: 367-74.
52. Eng RH, Padberg FT, Smith SM et al. Bactericidal effects of antibiotics on slowly growing and nongrowing bacteria. Antimicrob Agents Chemother 1991; 35: 1824-8.